The Path to a Cure: Treatment and Transplant

Treating Familial Hemophagocytic Lymphohistiocytosis (FHL) is a two-step journey. The first phase is about survival—stopping the “cytokine storm” that is damaging your child’s body. The second phase is about a permanent cure—replacing the faulty immune system with a new one through a Hematopoietic Stem Cell Transplant (HSCT) ^[1][2].

Phase 1: Calming the Storm (Induction)

The immediate goal is to bring the disease into remission. This is done using an “induction” protocol designed to quiet the overactive immune cells.

• HLH-94 Protocol: This is the international standard of care ^[3]. It typically lasts about 8 weeks and uses three main medications: Dexamethasone (a powerful steroid to reduce inflammation), Etoposide (a chemotherapy drug that removes overactive T cells), and later, Cyclosporine A (to suppress the immune system) ^[3][4].
• HLH-94 vs. HLH-2004: You may hear about a newer protocol called HLH-2004. While it was designed to improve results by moving Cyclosporine A to the very beginning, large studies have shown that it does not actually improve survival or reduce mortality compared to the original HLH-94 protocol ^[3][4]. Because HLH-94 is well-understood and effective, many specialists continue to prefer it as the first-line treatment ^[4][5].

Warning: Severe Infection Risk: These induction medications are incredibly powerful and intentionally turn off your child’s immune system to save their life. As a result, your child will be extremely vulnerable to opportunistic, life-threatening infections. Your child will likely require a central line (a semi-permanent IV) and may be placed in isolation ^[6]. Strict hygiene, isolation precautions, and prophylactic (preventative) antibiotics and antifungal medications are universally required during this dangerous period ^[7][6].

When Initial Treatment Isn’t Enough

Sometimes the standard chemotherapy does not fully “calm the storm.” This is known as refractory or relapsed HLH. In these cases, doctors may use newer, targeted therapies:

• Emapalumab (Gamifant): This is a specialized antibody that specifically targets and neutralizes interferon-gamma, a key chemical that fuels the cytokine storm ^[8][9]. It is FDA-approved for children with primary (familial) HLH when standard treatments haven’t worked or have caused too many side effects ^[10][11]. It can serve as a vital “bridge” to get a child stable enough for a transplant ^[12][13].

Phase 2: The Only Cure (HSCT)

Because FHL is caused by a genetic defect in the immune cells, medications can control the symptoms, but they cannot fix the underlying problem. Allogeneic Hematopoietic Stem Cell Transplant (HSCT) is currently the only curative treatment for FHL ^[1][2].

• The Procedure: Your child’s immune system is first cleared away using chemotherapy (called conditioning). Then, healthy stem cells from a donor—either a matched sibling, a matched unrelated donor, or a partially matched (“haploidentical”) family member—are infused into your child ^[14][15]. This process often requires the child to be in the hospital for many weeks or even months.
• Finding a Donor: Finding a suitable donor can take time. If a sibling is not a match, the medical team will search international bone marrow registries (such as Be The Match / NMDP) for an unrelated donor. This waiting period reinforces why Phase 1 (induction) is so critical as a stabilizing “bridge” while the search happens ^[1].
• The Importance of Remission: The chance of a successful transplant is generally higher if the disease is in complete remission (CR) before the procedure begins ^[14][1]. While a transplant can still be successful even if the disease is somewhat active, achieving a “quiet” immune system beforehand is a primary goal for the medical team to ensure the best possible outcome ^[14][16].

This path is intense and requires a dedicated team of specialists, but the combination of modern induction therapy and advanced transplant techniques has significantly improved the outlook for children diagnosed with FHL ^[17][14].